Login
Toggle navigation
Videos
Categories
Trending
Mike Crawley, CEO of Northland Power Inc., shares insights in "The View From The C-Suite" segment.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Mike Crawley. President/CEO, Northland Power Inc ;
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Nerdwallet founder and CEO Tim Chen discusses the company's quarterly earnings and lender tightening on 'Squawk Box'.|Tim Chen is the founder and CEO of NerdWallet.
00:10:00
Larry Fink's Call to Action for Boomer Responsibility and Future Generations | Larry Fink, CEO, BlackRock Inc.
00:10:00
Renowned Photographer Mike Butler Captures the Architectural Jewel of Bogot
00:10:00
PYX Resources: Leading the Global Mineral Sands Market
00:10:00
Challenges and Opportunities in Today's Investment Landscape | Abel Sithole, CEO , Public Investment Corporation.
00:10:00
Brisson on GFF: AIM Equity Insights | Ronald J. Kramer - Chairman of the Board and Chief Executive Officer of Griffon Corp
00:10:00
David Archer Highlights Savannah Resources' Mina do Barroso Lithium Project in Portugal.
00:10:00
address large-scale problems in human and environmental health|Gareth Asten,Managing Partner,Acre Venture Partners
00:10:00
Zynerba Pharmaceuticals Bolsters IP Portfolio for Zygel, Revolutionary Cannabidiol Clear Gel with Enhanced Transdermal Delivery| ARMANDO ANIDO , CHAIRMAN OF THE BOARD AND CHIEF EXECUTIVE OFFICER OF ZYNERBA PHARMACEUTICALS, INC
00:10:00
Azimut's Role in Empowering Italian SMEs and Savers | Paolo Martini, CEO , Azimut Holding.
00:10:00
Insights on Financial Inclusion: Bridging Gaps and Transforming Lives
00:10:00
High-Purity Manganese Sulfate Monohydrate for North American EV Sector